Silexion Therapeutics Corp.
04/25/2025 | Press release | Archived content
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 25, 2025 |
| Accession Number: | 0001178913-25-001407 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||